Overcome common and costly pitfalls in complex clinical diagnostics development
26 Aug 2025
Learn how DCN Dx’s multidisciplinary approach to IVD clinical research and regulatory services can streamline clinical diagnostics development by aligning clinical, regulatory, and technical teams from the start. In this interview, Patrick Vaughan, Chief Operating Officer, and Mitzi Rettinger, Chief Revenue Officer, DCN Dx, describe how the company’s integrated model prevents delays, optimizes assays, and ensures robust data management to help studies meet FDA expectations. With in-house experts and proactive issue resolution, DCN Dx helps clients avoid costly redesigns and accelerate time-to-market for innovative diagnostics.
SelectScience interview filmed at ADLM 2025.
About the company
DCN Dx
From early-stage assay development to clinical trials, regulatory support, and manufacturing, DCN Dx integrates seamlessly into your team to tackle challenges at any stage of IVD development. Its multidisciplinary experts provide comprehensive support tailored to your unique needs, delivering the insights, adaptability, and expertise you need to achieve breakthrough results.